Sun Pharma, Dr Reddy's Labs recall products in US over manufacturing issues
Dr Reddy's Laboratories and Sun Pharma, two prominent pharmaceutical companies, are conducting recalls of products in the United States following revelations of manufacturing issues. This action stems from the most recent Enforcement Report published by the US Food and Drug Administration (USFDA).
Dr Reddy's Laboratories is recalling medications used to treat insomnia and gout within the American market.
According to the USFDA, New Jersey-based Dr Reddy's Laboratories, Inc., a unit of the Hyderabad-based pharmaceutical giant, has initiated a recall of 13,752 bottles of Eszopiclone tablets, USP 1mg CIV, 30-count bottle, Rx only. The affected lot was manufactured at Dr Reddy's Bachupally plant located in Telangana.
The recall was prompted by concerns over "Failed Impurities/Degradation Specifications," leading to the issuance of a Class III nationwide recall on June 4 of this year.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.